Aytu BioPharma Ownership | Who Owns Aytu BioPharma?


OverviewRevenueFinancialsChartTranscripts

Aytu BioPharma Ownership Summary


Aytu BioPharma is owned by 30.59% institutional investors, 2.81% insiders, and 66.60% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.52% of its assets in Aytu BioPharma shares.

AYTU Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAytu BioPharma30.59%2.81%66.60%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustrySpecialty & Generic Drug Manufacturers Stocks2774.71%11.85%-2686.56%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202528-1,876,599-0.22%303.25%11-8.33%2-60.00%
Dec 31, 20242821.74%1,880,741-8.18%303.97%12140.00%5-28.57%
Sep 30, 202423-14.81%2,048,299-0.27%272.02%5-50.00%716.67%
Jun 30, 2024273.85%2,053,77514.39%373.52%10-16.67%620.00%
Mar 31, 20242618.18%1,795,4641.48%323.16%1220.00%5-16.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index32.37K0.52%275.00
Vanguard Institutional Extnd Mkt Idx Tr27.89K0.45%-
Spartan Extended Market Index Pool E11.89K0.19%280.00
Spartan Extended Market Index Pool F11.89K0.19%280.00
Fidelity Series Total Market Index8.05K0.13%-
Northern Trust Extended Eq Market Idx6.31K0.10%-
NT Ext Equity Mkt Idx Fd - L6.31K0.10%-
Dimensional US Sustainability Core 1 ETF3.85K0.06%-
DFA US Targeted Value I3.66K0.06%-5.01K
BlackRock Extended Equity Market K3.56K0.06%-2.00

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2025Disbrow Jarrett Chief Business OfficerBuy$25.00K
Jun 09, 2025Disbrow Joshua R. Chief Executive OfficerBuy$100.00K
Jun 06, 2025Nantahala Capital Management, LLC-Buy$400.00
Feb 28, 2025Disbrow Joshua R. Chief Executive OfficerBuy$19.50K
Jun 16, 2023PYSZCZYMUKA GREG Chief Commerical OfficerBuy$22.43K

Insider Transactions Trends


DateBuySell
2025 Q23-
2025 Q11-
2024 Q4--
2024 Q3--
2024 Q2--

AYTU Ownership FAQ


Who Owns Aytu BioPharma?

Aytu BioPharma shareholders are primarily institutional investors at 30.59%, followed by 2.81% insiders and 66.60% retail investors. The average institutional ownership in Aytu BioPharma's industry, Specialty & Generic Drug Manufacturers Stocks, is 2774.71%, which Aytu BioPharma falls below.

Does Blackrock own Aytu BioPharma?

BlackRock is not among the top 10 institutional shareholders of Aytu BioPharma.

Who is the top mutual fund holder of Aytu BioPharma shares?

Fidelity Extended Market Index is the top mutual fund holder of Aytu BioPharma shares, with 0.52% of its total shares outstanding invested in 32.37K Aytu BioPharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools